Overview

Mass Vaccine and Drug Administration, Bangladesh

Status:
Not yet recruiting

Trial end date:
2028-02-01

Target enrollment:

Participant gender:

Summary

This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug administrations, mass vaccinations, combined mass vaccinations and drug administrations versus the current standard of care.

Phase:

Phase 4

Details

Lead Sponsor:

University of Oxford

Treatments:

Piperaquine